Trump wants to work with Democrats on drug prices, infrastructure: aide

Published 03/26/2019, 12:04 PM
© Reuters. FILE PHOTO - Bottles of medications line the shelves at a pharmacy in Portsmouth

WASHINGTON (Reuters) - U.S. President Donald Trump is willing to work with congressional Democrats to lower drug prices for Americans and on infrastructure funding, White House adviser Kellyanne Conway said on Tuesday.

Conway said the Trump administration considered those two issues as areas of cooperation between Democrats and the Republican president.

Trump said in January that he expected to see a tremendous decrease in drug prices even as drugmakers have taken steps to raise the prices of medicines starting this month.

According to documents seen by Reuters, nearly 30 pharmaceutical companies have taken steps to end their self-declared halt to price increases this year.

Leaders in the Democrat-controlled House of Representatives say the high cost of prescription drug prices is a top priority for the year. Powerful committees held hearings in January on the matter.

© Reuters. FILE PHOTO - Bottles of medications line the shelves at a pharmacy in Portsmouth

The Republican-controlled Senate Finance Committee has invited executives from five pharmacy benefit managers to testify on April 3 on the rising costs of prescription medicines.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.